Trial intelligence / Profile preview

Dexamethasone pretreatment to prevent etomidate-induced myoclonus

ChiCTR2000035765Phase 4Recruiting

Sponsor
Nanchong City Central Hospital
Start
Oct 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexamethasone in myoclonus (3 arms), sponsored by Nanchong City Central Hospital. Primary endpoint: Incidence of myoclonus. Started Oct 2020; status: recruiting.

02

Drugs

dexamethasone
03

Conditions

myoclonus

Beyond the preview

Go deeper on ChiCTR2000035765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call